EDGAR Filing Documents for 0001144204-15-059667

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001144204-15-059667

Filing Date

2015-10-16

Accepted

2015-10-15 19:02:23

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	v421994_s3.htm	S-3	532027
2	EXHIBIT 5.1	v421994_ex5-1.htm	EX-5.1	39214
3	EXHIBIT 23.1	v421994_ex23-1.htm	EX-23.1	3666
4	EXHIBIT 23.2	v421994_ex23-2.htm	EX-23.2	3839
5	GRAPHIC	tpg35.jpg	GRAPHIC	103274
6	GRAPHIC	tpg37.jpg	GRAPHIC	71928
	Complete submission text file	0001144204-15-059667.txt		821465

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: S-3 | Act: 33 | File No.: 333-207443 | Film No.: 151160904
SIC: 2834 Pharmaceutical Preparations